Showing results (101-110 of 217) with videos related to

Sort By:
Pageof 22
Vaccines|January 22, 2022
Harnessing Mycobacterium bovis BCG Trained Immunity to Control Human and Bovine BabesiosisReginaldo G Bastos, Heba F Alzan, Vignesh A Rathinasamy, et al.
NPJ Vaccines|September 27, 2023
Vaccination of cattle with the Babesia bovis sexual-stage protein HAP2 abrogates parasite transmission by Rhipicephalus microplus ticksMarta G Silva, Reginaldo G Bastos, Jacob M Laughery, et al.
Parasites & Vectors|April 21, 2021
Assessment of Babesia bovis 6cys A and 6cys B as components of transmission blocking vaccines for babesiosisHeba F Alzan, Reginaldo G Bastos, Massaro W Ueti, et al.
Lab on a Chip|June 13, 2022
Rapid microfluidic platform for screening and enrichment of cells secreting virus neutralizing antibodiesWeikang Nicholas Lin, Matthew Zirui Tay, Joel Xu En Wong, et al.
European Journal of Immunology|March 11, 2014
CD41 is a reliable identification and activation marker for murine basophils in the steady state and during helminth and malarial infectionsNadja Bakocevic, Carla Claser, Soichiro Yoshikawa, et al.
ACS Infectious Diseases|May 22, 2023
Plasmodium falciparum Eukaryotic Translation Initiation Factor 3 is Stabilized by Quinazoline-Quinoline Bisubstrate InhibitorsIrina Dobrescu, Elie Hammam, Jerzy M Dziekan, et al.
The Journal of Cell Biology|March 8, 2006
A Maurer's cleft-associated protein is essential for expression of the major malaria virulence antigen on the surface of infected red blood cellsBrian M Cooke, Donna W Buckingham, Fiona K Glenister, et al.
The Journal of Infectious Diseases|March 7, 2006
Liver-stage development of Plasmodium falciparum, in a humanized mouse modelSerban Morosan, Stéphanie Hez-Deroubaix, Francoise Lunel, et al.
Infection and Immunity|May 25, 2004
Antibodies against MAEBL ligand domains M1 and M2 inhibit sporozoite development in vitroPeter Preiser, Laurent Rénia, Naresh Singh, et al.
Pageof 22